Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | MLN1202 |
Trade Name | |
Synonyms | Plozalizumab|TAK-202 |
Drug Descriptions |
Plozalizumab (MLN1202) is a monoclonal antibody that binds to and inhibits human chemokine receptor 2 (CCR2), potentially resulting in decreased tumor cell migration and proliferation (PMID: 21247529). |
DrugClasses | |
CAS Registry Number | 1610761-46-0 |
NCIT ID | C88308 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
MLN1202 | MLN1202 | 0 | 0 |
MLN1202 + Nivolumab | MLN1202 Nivolumab | 0 | 1 |